You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR OXYCODONE AND ASPIRIN (HALF-STRENGTH)

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for OXYCODONE AND ASPIRIN (HALF-STRENGTH)

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00771758 ↗	Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis	Completed	Grünenthal GmbH	Phase 3	2008-09-01	The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00771758 ↗	Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis	Completed	Ortho-McNeil Janssen Scientific Affairs, LLC	Phase 3	2008-09-01	The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00814580 ↗	Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery	Completed	Grünenthal GmbH	Phase 3	2008-12-01	The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
NCT00814580 ↗	Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery	Completed	Ortho-McNeil Janssen Scientific Affairs, LLC	Phase 3	2008-12-01	The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
NCT01080677 ↗	Caffeine/Propranolol Intervention for Acute Migraine	Completed	Stanford University	Phase 2	2007-01-01	This is a research study to assess the safety of caffeine/propranolol at different dose levels. We want to find out what effects, good and/or bad, it has on patients and their migraines.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for OXYCODONE AND ASPIRIN (HALF-STRENGTH)

Condition Name

Chart
Table

Condition Name for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Intervention	Trials
Back Pain	1
Essential Thrombocythemia	1
Migraine Disorders	1
Polycythemia Vera	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Intervention	Trials
Pain, Postoperative	2
Fractures, Compression	1
Thrombocythemia, Essential	1
Back Pain	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for OXYCODONE AND ASPIRIN (HALF-STRENGTH)

Trials by Country

Map
Table

Trials by Country for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Location	Trials
United States	24
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Location	Trials
North Carolina	3
New York	3
California	2
Arizona	2
Ohio	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for OXYCODONE AND ASPIRIN (HALF-STRENGTH)

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	2
Phase 2	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Clinical Trial Phase	Trials
Completed	4
Unknown status	1
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for OXYCODONE AND ASPIRIN (HALF-STRENGTH)

Sponsor Name

Chart
Table

Sponsor Name for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Sponsor	Trials
Grünenthal GmbH	2
Ortho-McNeil Janssen Scientific Affairs, LLC	2
John Mascarenhas	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for OXYCODONE AND ASPIRIN (HALF-STRENGTH)
Sponsor	Trials
Industry	6
Other	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.